From Bioinformatics.Org Wiki
Dr. Narayanan serves as Associate Dean for Research and Industry Relations, and Assistant Director for the Center for Molecular Biology and Biotechnology in the Charles E. Schmidt College of Science at Florida Atlantic University. He received his Ph.D in Biochemistry in 1980 from the National University of Dublin in Ireland. He did his postdoctoral work at the National Cancer Institute, NIH and at the U.S. Centers for Disease Control. Subsequently, Dr. Narayanan continued his training at Yale University and the Memorial Sloan-Kettering Cancer Center. Over the course of ten years at Hoffmann-La Roche, Inc. in Nutley, NJ, he developed his expertise in biotechnology, bioinformatics, molecular medicine, drug discovery and cancer research. A leader in antisense technology and bioinformatics, Dr. Narayanan has concentrated his research efforts on solid tumors.
Dr. Narayanan joined FAU as a professor in Biological Sciences in 1998 to help the College of Science create a biotechnology infrastructure. Since then, he has worked as Associate and Acting Director for the Center for Molecular Biology and Biotechnology, Director of the Integrative Biology Ph.D Program, Associate Dean for Research and Industrial Relations, Assistant VP for Research and Chair of Chemistry and Biochemistry in the Charles E. Schmidt College of Science.
His work at FAU has led to two issued patents and provided the basis for the first biotech startup at the University. He has published over 70 peer-reviewed publications and numerous book chapters. He is on the editorial boards of Antisense Research & Development, Anticancer Research, In Vivo and Current Cancer Therapy reviews. He has given lectures and seminars at Karolinska Institute, Sweden; Katholieke Universiteit, Leuven, Belgium; The Netherlands Cancer Institute, Amsterdam; Tokushima University, Japan; Sylvester Cancer Center, University of Miami; Florida State University; Washington University, St. Louis; Human Genome Sciences and others. He is a reviewer for NCI study sections and has been a site visit member for NCI and numerous European funding agencies.